Singapore Markets closed

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6900+0.0158 (+2.34%)
At close: 04:00PM EDT
0.6900 0.00 (0.00%)
After hours: 07:47PM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 37.2400
52-week low 30.6100
50-day moving average 31.6738
200-day moving average 32.9019

Share statistics

Avg vol (3-month) 312.09M
Avg vol (10-day) 33.87M
Shares outstanding 5129.98M
Implied shares outstanding 6N/A
Float 8140.26M
% held by insiders 11.43%
% held by institutions 138.62%
Shares short (28 Apr 2022) 427.71M
Short ratio (28 Apr 2022) 41.27
Short % of float (28 Apr 2022) 419.64%
Short % of shares outstanding (28 Apr 2022) 419.26%
Shares short (prior month 30 Mar 2022) 421.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin -177.82%
Operating margin (ttm)-147.89%

Management effectiveness

Return on assets (ttm)-25.50%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)148.76M
Revenue per share (ttm)1.29
Quarterly revenue growth (yoy)-16.90%
Gross profit (ttm)115.3M
EBITDA -211.5M
Net income avi to common (ttm)-264.52M
Diluted EPS (ttm)-2.7810
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)143.43M
Total cash per share (mrq)1.01
Total debt (mrq)638.37M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.58
Book value per share (mrq)-1.76

Cash flow statement

Operating cash flow (ttm)-196.06M
Levered free cash flow (ttm)-108.2M